Development of a bispecific immunotracer targeting CD69 and CD8β for enhanced non-invasive imaging of immune responses during anti-cancer immunotherapy

Tessa De Pauw (VUB)
Presentation: “Development of a bispecific immunotracer targeting CD69 and CD8β for enhanced non-invasive imaging of immune responses during anti-cancer immunotherapy”

Introducing an innovative dual-targeting approach, Tessa De Pauw presented her work on a bispecific immunotracer targeting CD69 and CD8β. This strategy aims to improve the specificity and sensitivity of imaging immune responses during cancer immunotherapy. By enabling more detailed visualisation of immune activation, her research contributes to a deeper understanding of treatment effects and supports the development of more precise tools for monitoring therapy response. This work represents an important step forward in advancing non-invasive imaging techniques in oncology.